ghk-cu hair growth human trial GHK Peptide Clinical (2016) — Research Summary GHK-Cu for Hair Loss: What

This is important because appetite and energy balance are not controlled only by the stomach or digestive system

8 weeks (~75 mg/day avg): ~9 vials 12 weeks: ~13 vials 16 weeks: ~17 vials Insulin Syringes (U-100, 1 mL) Per injection: 1 syringe 8 weeks (once daily): ~56 syringes 16 weeks (once daily): ~112 syringes Bacteriostatic Water (10 mL bottles) Use 5.0 mL per 500 mg vial for reconstitution

Common side effects include redness or swelling at the injection site, mild diarrhea, and a temporary feeling of lightheadedness

In 2019, cancer was responsible for the deaths of over ten million people, making them the second leading cause of death after cardiovascular diseases [1]

Individuals with a personal or family history of thyroid tumours should be aware that, in common with other GLP-1 receptor agonists, retatrutide's GLP-1 activity may carry a theoretical thyroid risk

N Engl J Med 2016;375:31122.ArticlePubMedPMC 46